BionorthTX Names Pharma Entrepreneur, Investor, and Philanthropist as Stone Award Recipient » Dallas Innovates


North Texas has a booming biotech sector that includes Fort Worth businessman Paul Dorman, the chairman and CEO of DFB Pharmaceuticals who has a strong record as an entrepreneur, investor, and philanthropist. And bionorthTX, North Texas’ life sciences trade association, recognizes that.

Dorman has been named as the recipient of bionorthTX’s 2019 Dennis K. Stone Award, which recognizes contributions that have improved the community’s quality of life.

Dorman will receive the award on Friday, Sept. 27 at the 5th Annual iC3 Life Science Summit in Arlington.

The Summit was launched in 2014 as a meeting place for startups and large multinationals in biotech, pharma, healthcare, academic research, innovation, and more. Each year, the event is a forum for leaders to discuss strategic issues, exhibit a variety of local life sciences products and services, network, and grow business through collaboration.




Please enter your comment!
Please enter your name here